Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in China
Phase of Trial: Phase IV
Latest Information Update: 11 May 2017
At a glance
- Drugs Adalimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors AbbVie
- 03 Feb 2017 Planned End Date changed from 1 Sep 2017 to 1 Jun 2018.
- 03 Feb 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Jun 2018.
- 03 Jun 2016 Status changed from not yet recruiting to recruiting.